BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17372055)

  • 1. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
    Machens A; Ukkat J; Hauptmann S; Dralle H
    Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skip metastases in thyroid cancer leaping the central lymph node compartment.
    Machens A; Holzhausen HJ; Dralle H
    Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
    Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of lateral lymph node metastases in medullary thyroid cancer.
    Machens A; Hauptmann S; Dralle H
    Br J Surg; 2008 May; 95(5):586-91. PubMed ID: 18300267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lack of prognostic significance of carcinoembryonic antigen (CEA) preoperative serum levels in patients with advanced larynx cancer].
    Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
    Przegl Lek; 2006; 63(2):68-71. PubMed ID: 16969905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma presenting with an initial CEA elevation.
    Abraham D; Delbridge L; Clifton-Bligh R; Clifton-Bligh P; Grodski S; Robinson BG; Messina M; Sidhu S
    ANZ J Surg; 2010 Nov; 80(11):831-3. PubMed ID: 20969693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
    Machens A; Dralle H
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2655-63. PubMed ID: 20339026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma.
    Machens A; Holzhausen HJ; Dralle H
    Br J Surg; 2004 Jun; 91(6):709-12. PubMed ID: 15164439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
    Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
    Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
    Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
    Ebeling FC; Schmitt UM; Untch M; Nagel D; Fateh-Moghadam A; Stieber P; Seidel D
    Anticancer Res; 1999; 19(4A):2545-50. PubMed ID: 10470192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
    Machens A; Hauptmann S; Dralle H
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
    Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
    J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.